Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Diakonos Oncology Corporation

Diakonos Oncology Receives FDA Fast Track Designation for Pancreatic Cancer Dendritic Cell Vaccine; Names Daniel D. Von Hoff, M.D. to Scientific Advisory Board
From Diakonos Oncology Corporation
Via Business Wire
Diakonos Oncology to Present at the Emerging Growth Conference
From Diakonos Oncology Corporation
Via Business Wire
Diakonos Oncology Completes Phase 1 Glioblastoma Trial Recruitment; Receives FDA Orphan Drug Designation
From Diakonos Oncology Corporation
Via Business Wire
Diakonos Oncology Names Ian H. Bellayr, Ph.D. Chief Regulatory Officer
From Diakonos Oncology Corporation
Via Business Wire
Diakonos Oncology Awarded FDA Fast Track Designation for Innovative Dendritic Cell Vaccine for Glioblastoma
From Diakonos Oncology Corporation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.